Jacob M. Kaufman

1.1k total citations
12 papers, 191 citations indexed

About

Jacob M. Kaufman is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacob M. Kaufman has authored 12 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacob M. Kaufman's work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers) and RNA modifications and cancer (2 papers). Jacob M. Kaufman is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers) and RNA modifications and cancer (2 papers). Jacob M. Kaufman collaborates with scholars based in United States and Japan. Jacob M. Kaufman's co-authors include David P. Carbone, Joseph M. Amann, Kyungho Park, Yu Shyr, Rajeswara Rao Arasada, Haotian Li, Wiktor Piecek, Piotr Kaszyński, S.M. Jamshedur Rahman and Lisa J. Zimmerman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jacob M. Kaufman

11 papers receiving 191 citations

Peers

Countries citing papers authored by Jacob M. Kaufman

Since Specialization

Citations

This map shows the geographic impact of Jacob M. Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob M. Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob M. Kaufman more than expected).

Fields of papers citing papers by Jacob M. Kaufman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob M. Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob M. Kaufman. The network helps show where Jacob M. Kaufman may publish in the future.

Co-authorship network of co-authors of Jacob M. Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob M. Kaufman. A scholar is included among the top collaborators of Jacob M. Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob M. Kaufman. Jacob M. Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis 2025 ·Journal for ImmunoTherapy of Cancer ·C. G. Wood, (unknown), (unknown), Jacob M. Kaufman, (unknown), (unknown), Jeffrey Crawford, Thomas E. Stinchcombe, Betty Tong, Xiaofei Wang, Lin Gu, Dennis A. Wigle, Konstantin H. Dragnev, Scott Antonia, Kent J. Weinhold, Neal Ready	1
2	CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches 2025 ·Journal of the National Comprehensive Cancer Network ·(unknown), Natalie Johns, Songzhu Zhao, (unknown), Po‐Lan Su, (unknown), (unknown), Daniel Spakowicz, Lai Wei, (unknown), (unknown), Regan M. Memmott, Jacob M. Kaufman, Carolyn J. Presley, Kai He, Peter G. Shields, Christian Rolfo, David P. Carbone, Mingjia Li, Dwight H. Owen	1
3	P3.12D.01 A Phase Ib Study of Osimertinib and Tegavivint as First-Line Therapy in Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) 2024 ·Journal of Thoracic Oncology ·(unknown), (unknown), Lai Wei, (unknown), Wenxian Yang, (unknown), Stephen Horrigan, Andrew W. Duncan, (unknown), Giovanni Amato, (unknown), Jacob M. Kaufman, Ahlam A. Alahmadi, Carolyn J. Presley, Dwight H. Owen, David P. Carbone	0
4	Real world outcomes of patients treated with first line chemo-immunotherapy (IO) for small cell lung cancer (SCLC): Impact of brain metastases and patterns of subsequent therapy. 2023 ·Journal of Clinical Oncology ·Saira Farid, Songzhu Zhao, Sandip H. Patel, (unknown), (unknown), Lai Wei, Mingjia Li, Joshua D. Palmer, Sasha Beyer, Raju R. Raval, Peter G. Shields, Kai He, Jacob M. Kaufman, Regan M. Memmott, (unknown), David P. Carbone, Gregory A. Otterson, Carolyn J. Presley, Dwight H. Owen	1
5	STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S -Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma 2021 ·Cancer Research ·Michael J. Koenig, (unknown), Jacob M. Kaufman, (unknown), Walter Wang, Christoph Weigel, Fábio C. P. Navarro, Joseph M. Amann, (unknown), Rajeswara Rao Arasada, Mark Gerstein, Vicki H. Wysocki, Christopher C. Oakes, David P. Carbone	10
6	909 Differentiation subgroups within LKB1-deficient lung cancer influence both the immune exclusion phenotype and cellular composition of the immune microenvironment 2021 ·SHILAP Revista de lepidopterología ·Jacob M. Kaufman, (unknown), Theresa A. Boyle, David P. Carbone, Neal Ready, Kris C. Wood	1
7	A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma 2016 ·Cancer Research ·Jacob M. Kaufman, Tadaaki Yamada, Kyungho Park, Cynthia Timmers, Joseph M. Amann, David P. Carbone	19
8	LKB1 Loss Induces Characteristic Patterns of Gene Expression in Human Tumors Associated with NRF2 Activation and Attenuation of PI3K-AKT 2014 ·Journal of Thoracic Oncology ·Jacob M. Kaufman, Joseph M. Amann, Kyungho Park, Rajeswara Rao Arasada, Haotian Li, Yu Shyr, David P. Carbone	59
9	In-depth Proteomic Analysis of Nonsmall Cell Lung Cancer to Discover Molecular Targets and Candidate Biomarkers 2012 ·Molecular & Cellular Proteomics ·Takefumi Kikuchi, Mohamed Hassanein, Joseph M. Amann, Qinfeng Liu, Robbert J.C. Slebos, S.M. Jamshedur Rahman, Jacob M. Kaufman, Xueqiong Zhang, Megan D. Hoeksema, Bradford K. Harris, Ming Li, Yu Shyr, Adriana L. Gonzalez, Lisa J. Zimmerman, D.C. Liebler, Pierre P. Massion, David P. Carbone	61
10	Long-term Smoking Mediated Down-regulation of Smad3 Induces Resistance to Carboplatin in Non-Small Cell Lung Cancer 2012 ·Neoplasia ·Debangshu Samanta, Jacob M. Kaufman, David P. Carbone, Pran K. Datta	15
11	B358 SF1126, A Novel PI3K Inhibitor Results in Downstream Inhibition of the PI3K Axis and Displays Sequen 2009 ·Clinical Lymphoma & Myeloma ·Ebenezer David, Sagar Lonial, Benjamin G. Barwick, Xiaolan Peng, Jacob M. Kaufman, Joseph R. Garlich	1
12	A comparison of mesogenic properties for one- and two-ring dipentyl derivatives ofp-carboranes, bicyclo[2.2.2]octane, and benzene 2003 ·Liquid Crystals ·Wiktor Piecek, Jacob M. Kaufman, Piotr Kaszyński	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact